BR9508584A - Processo para tratamento de um indivíduo para endotoxemia e para alivio utilizável no tratamento de endotoxemia - Google Patents

Processo para tratamento de um indivíduo para endotoxemia e para alivio utilizável no tratamento de endotoxemia

Info

Publication number
BR9508584A
BR9508584A BR9508584A BR9508584A BR9508584A BR 9508584 A BR9508584 A BR 9508584A BR 9508584 A BR9508584 A BR 9508584A BR 9508584 A BR9508584 A BR 9508584A BR 9508584 A BR9508584 A BR 9508584A
Authority
BR
Brazil
Prior art keywords
endotoxemia
relief
usable
treating
individual
Prior art date
Application number
BR9508584A
Other languages
English (en)
Inventor
Daniel M Levine
Thomas S Parker
Albert L Rubin
Bruce R Gordon
Stuart D Saal
Original Assignee
Rogosin Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26965092&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR9508584(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/288,568 external-priority patent/US5506218A/en
Application filed by Rogosin Inst filed Critical Rogosin Inst
Publication of BR9508584A publication Critical patent/BR9508584A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1275—Lipoproteins; Chylomicrons; Artificial HDL, LDL, VLDL, protein-free species thereof; Precursors thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775—Apolipopeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Dispersion Chemistry (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
BR9508584A 1994-08-10 1995-08-10 Processo para tratamento de um indivíduo para endotoxemia e para alivio utilizável no tratamento de endotoxemia BR9508584A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/288,568 US5506218A (en) 1992-08-12 1994-08-10 Methods useful in endotoxin based therapy
US08/487,459 US5674855A (en) 1992-08-12 1995-06-07 Methods and compositions useful in prophylaxis and therapy of endotoxin related conditions
PCT/US1995/010189 WO1996004916A1 (en) 1994-08-10 1995-08-10 Methods and compositions useful in prophylaxis and therapy of endotoxin related conditions

Publications (1)

Publication Number Publication Date
BR9508584A true BR9508584A (pt) 1997-10-21

Family

ID=26965092

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9508584A BR9508584A (pt) 1994-08-10 1995-08-10 Processo para tratamento de um indivíduo para endotoxemia e para alivio utilizável no tratamento de endotoxemia

Country Status (27)

Country Link
US (1) US5674855A (pt)
EP (1) EP0767666B1 (pt)
JP (1) JP3818660B2 (pt)
CN (1) CN1137688C (pt)
AP (1) AP782A (pt)
AT (1) ATE255415T1 (pt)
AU (1) AU703861C (pt)
BG (1) BG61967B1 (pt)
BR (1) BR9508584A (pt)
CA (1) CA2196906C (pt)
CY (1) CY2514B1 (pt)
CZ (1) CZ287614B6 (pt)
DE (1) DE69532239T2 (pt)
DK (1) DK0767666T3 (pt)
ES (1) ES2211915T3 (pt)
FI (1) FI118035B (pt)
HK (1) HK1003709A1 (pt)
HU (1) HUT77605A (pt)
NO (1) NO313786B1 (pt)
NZ (1) NZ292315A (pt)
OA (2) OA11737A (pt)
PL (1) PL182043B1 (pt)
PT (1) PT767666E (pt)
RO (1) RO115782B1 (pt)
RU (1) RU2174839C2 (pt)
SK (1) SK282493B6 (pt)
WO (1) WO1996004916A1 (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6037323A (en) * 1997-09-29 2000-03-14 Jean-Louis Dasseux Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
US6004925A (en) 1997-09-29 1999-12-21 J. L. Dasseux Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
US6046166A (en) 1997-09-29 2000-04-04 Jean-Louis Dasseux Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
US6518412B1 (en) 1997-09-29 2003-02-11 Jean-Louis Dasseux Gene therapy approaches to supply apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
DK1158989T3 (da) * 1999-03-09 2007-10-22 Anker Stefan Anvendelse af inhibitorer af endotoksin til behandling af kakeksi
US20030032674A1 (en) * 2001-08-13 2003-02-13 Hwang Daniel H. Use of unsaturated fatty acids to treat severe inflammatory diseases
WO2003096983A2 (en) 2002-05-17 2003-11-27 Esperion Therapeutics, Inc. Method of treating dyslipidemic disorders
WO2004068969A1 (en) * 2003-02-05 2004-08-19 N.V. Nutricia Enteral composition for the prevention and/or treatment of sepsis
US20060127468A1 (en) 2004-05-19 2006-06-15 Kolodney Michael S Methods and related compositions for reduction of fat and skin tightening
US7754230B2 (en) * 2004-05-19 2010-07-13 The Regents Of The University Of California Methods and related compositions for reduction of fat
DK1758590T3 (da) * 2004-05-19 2011-11-21 Los Angeles Biomed Res Inst Anvendelse af et detergent til ikke-kirurgisk fjernelse af fedt
KR101413361B1 (ko) * 2005-08-29 2014-06-27 셉시큐어,엘.엘.씨. 그람-양성 박테리아에 의해 유발되는 질병의 치료 또는예방 방법
GB0522942D0 (en) 2005-11-10 2005-12-21 Leigh Steven Dissolution composition
EP2537526A1 (en) 2006-06-01 2012-12-26 Institut de Cardiologie de Montréal Method and compound for the treatment of valvular stenosis
KR100785656B1 (ko) * 2007-05-14 2007-12-17 재단법인서울대학교산학협력재단 소염제로 사용되는 소디움글리코콜레이트 또는 그 유도체
RU2532222C2 (ru) 2009-02-16 2014-10-27 Серенис Терапьютикс Холдинг С.А, Миметики аполипопротеина а-i
US8101593B2 (en) 2009-03-03 2012-01-24 Kythera Biopharmaceuticals, Inc. Formulations of deoxycholic acid and salts thereof
US20120237492A1 (en) 2011-02-18 2012-09-20 Kythera Biopharmaceuticals, Inc. Treatment of submental fat
US8653058B2 (en) 2011-04-05 2014-02-18 Kythera Biopharmaceuticals, Inc. Compositions comprising deoxycholic acid and salts thereof suitable for use in treating fat deposits
US9023833B2 (en) * 2012-12-18 2015-05-05 Sepsicure, LLC Method for treating sepsis in patients with albumin, cholesterol and HDL levels above minimum thresholds

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4115313A (en) * 1974-10-08 1978-09-19 Irving Lyon Bile acid emulsions
DE2556592C2 (de) * 1975-12-16 1986-10-09 A. Nattermann & Cie GmbH, 5000 Köln Arzneimittelzubereitungen auf Basis öliger Lösungen von Phospholipiden
US4314997A (en) * 1980-10-06 1982-02-09 Edward Shanbrom Purification of plasma protein products
IL63734A (en) * 1981-09-04 1985-07-31 Yeda Res & Dev Lipid fraction,its preparation and pharmaceutical compositions containing same
CA1237671A (en) * 1983-08-01 1988-06-07 Michael W. Fountain Enhancement of pharmaceutical activity
JPS6193111A (ja) * 1984-05-28 1986-05-12 Funayama Seizo 発熱性物質除去方法
US5032585A (en) * 1987-02-17 1991-07-16 Board Of Regents, The University Of Texas System Methods and compositions employing unique mixtures of polar and neutral lipids for surfactant replacement therapy
AU614465B2 (en) * 1989-04-05 1991-08-29 Yissum Research Development Company Of The Hebrew University Of Jerusalem Medicinal emulsions
DE4017979A1 (de) * 1990-06-05 1991-12-12 Meyer Lucas Gmbh & Co Lipid- bzw. phospholipid-zusammensetzungen sowie diese enthaltendes mittel zur behandlung von erkrankungen sowie auf die zellmembrane zurueckzufuehrende stoerungen
BR9201168A (pt) * 1992-04-02 1994-04-12 Zerbini E J Fundacao Microemulsoes usadas como velculo para carregar quimioterapicos as celulas neoplasicas

Also Published As

Publication number Publication date
AU703861B2 (en) 1999-04-01
NO970582L (no) 1997-04-07
CN1158087A (zh) 1997-08-27
AU3405295A (en) 1996-03-07
CA2196906C (en) 2004-03-02
DE69532239D1 (de) 2004-01-15
AU703861C (en) 2001-12-20
NZ292315A (en) 1998-10-28
EP0767666A4 (en) 1998-10-07
EP0767666A1 (en) 1997-04-16
CN1137688C (zh) 2004-02-11
CA2196906A1 (en) 1996-02-22
PL182043B1 (pl) 2001-10-31
AP782A (en) 1999-11-15
CY2514B1 (en) 2005-12-23
ES2211915T3 (es) 2004-07-16
JPH10504037A (ja) 1998-04-14
DK0767666T3 (da) 2004-04-05
US5674855A (en) 1997-10-07
ATE255415T1 (de) 2003-12-15
RU2174839C2 (ru) 2001-10-20
CZ287614B6 (en) 2001-01-17
RO115782B1 (ro) 2000-06-30
WO1996004916A1 (en) 1996-02-22
EP0767666B1 (en) 2003-12-03
JP3818660B2 (ja) 2006-09-06
CZ37197A3 (en) 1997-10-15
DE69532239T2 (de) 2004-10-21
FI118035B (fi) 2007-06-15
PL318593A1 (en) 1997-06-23
SK17697A3 (en) 1997-09-10
BG101288A (en) 1997-09-30
PT767666E (pt) 2004-04-30
NO313786B1 (no) 2002-12-02
NO970582D0 (no) 1997-02-07
FI970534A (fi) 1997-02-07
OA11737A (en) 2005-05-12
BG61967B1 (bg) 1998-11-30
HK1003709A1 (en) 1998-11-06
FI970534A0 (fi) 1997-02-07
AP9700921A0 (en) 1997-01-31
SK282493B6 (sk) 2002-02-05
OA10598A (en) 2002-07-15
HUT77605A (hu) 1998-06-29

Similar Documents

Publication Publication Date Title
BR9508584A (pt) Processo para tratamento de um indivíduo para endotoxemia e para alivio utilizável no tratamento de endotoxemia
BR9510077A (pt) Aparelho e processo para tratamento e distribuição de águas servidas
BR9612228A (pt) Aparelho para o tratamento da exaustão em máquinas e método de utilização
BR9305667A (pt) Processo e aparelho para monitoraçao de tratamento de hemodiálise
BR9510632A (pt) Método e aparelho para tratamento de superfície eletroquímico
BR9508906A (pt) Processo e aparelho para executar transações diferidas
BR9610522A (pt) Composição para lavagem do corpo e processo para o tratamento da pele
KR960008976A (ko) 처리장치 및 처리방법
BR9701152A (pt) Processo e aparelho para eliminação de interferência
BR9206487A (pt) Processo e dispositivo para uso no tratamento de cabelo
DE69417545D1 (de) Kühlmittelaufbereitungsverfahren und Vorrichtung
BR9507568A (pt) Aparelho e processo de revestimento
BR9508336A (pt) Processo e dispositivo para retificação de excêntricos com flancos côncavos
BR9608091A (pt) Aparelho para usinar orifícios em árvores de manivelas e processo para usinar árvores de manivelar
BR9105287A (pt) Composicao e processo para o tratamento do cabelo
BR9501678A (pt) Preparação e método para tratamento dos cabelos
BR8901135A (pt) Composicao para condicionamento de tecido e processo para tratar tecidos
BR9507567A (pt) Dispositivo e processo de revestimento por matriz
BR9502904A (pt) Processo e dispositivo para o tratamento posterior de folhas de chapa soldadas
BR9501179A (pt) Processo de enxerto e dispositivo para o mesmo
BR9606925A (pt) Utilização de compostos e processo para o tratamento e profilaxia da obesidade
BR9101496A (pt) Processo para tratamento de tecidos
PT880903E (pt) Aparelho e processo para o tratamento da atmosfera contida em espacos fechados
BR9505498A (pt) Processo de secagem e aparelho para secagem
BR9002097A (pt) Processo e aparelho para o tratamento de metal em fusao

Legal Events

Date Code Title Description
PC Transfer

Free format text: SEPSICURE, L.L.C. (US)

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 29/08/2006, OBSERVADAS AS CONDICOES LEGAIS.

B22O Other matters related to patents and certificates of addition of invention: legal action concerning patent

Free format text: INPI-52400.061557/2013 ORIGEM: JUIZO DA 013A VARA FEDERAL DO RIO DE JANEIRO PROCESSO NO 0132378-91.2013.4.02.5101 ACAO DE NULIDADE DAS PATENTES SUBMETIDAS AO MAILBOX (ART. 229, PARAGRAFO UNICO DA LPI); ALTERNATIVAMENTE, A DECRETACAO DA NULIDADE PARCIAL PARA CORRECAO DO PRAZO DE VIGENCIA; SUBSIDIARIAMENTE, CASO SE ENTENDA NAO SER O CASO DE NULIDADE, A CORRECAO DO ATO ADMINISTRATIVO PARA ADEQUACAO DA VIGENCIA DAS PATENTES. AUTOR: INSTITUTO NACIONAL DA PROPRIEDADE INDUSTRIAL - INPI REU: RECKITT BENCKISER HEALTHCARE (UK) LIMITED, SANOFI-AVERTIS, SEPSICURE, L.L.C, THE AUSTRALIAN NATIONAL UNIVERSITY, THE PROVOST FELLOWS AND SCHOLARS OF THE COLLEGE OF THE HOLY UNDIVIDED TRINITY OF QUEEN ELIZA

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: REFERENTE A RPI 1860 DE 29/08/2006, QUANTO AO PRAZO DE VALIDADE CONFORME DECISAO DA 13A VARA FEDERAL DO RIO DE JANEIRO.

B19A Notification of judicial decision: notification of judicial decision

Free format text: INPI-52400.061557/13 SECAO JUDICIARIA DO RIO DE JANEIRO - 13A VARA FEDERAL PROCESSO NO 2013.51.01.132378-8 AUTOR: INSTITUTO NACIONAL DA PROPRIEDADE INDUSTRIAL - INPI REU(S): RECKITT BENCKISER HEALTHCARE (UK) LIMITED, SANOFI-AVENTIS, SEPSICURE, L.L.C. E THE AUSTRALIAN NATIONAL UNIVERSITY DECISAO: ANTECIPO OS EFEITOS DA TUTELA, A FIM DE DETERMINAR A IMEDIATA READEQUACAO DO PRAZO DE VIGENCIA DAS PATENTES PI9607679-8, PI9707943-0, PI9508584-0 E PI9608041-8 PARA VINTE ANOS CONTADOS A PARTIR DOS RESPECTIVOS DEPOSITOS, NOS TERMOS DO PARAGRAFO UNICO DO ART. 229 C/C O CAPUT DO ART. 40 DA LPI, CONFORME TABELA A SEGUIR: TITULAR: RECKITT BENCKISER HEALTHCARE (UK) LIMITED - PI9607679-8 - PRAZO DE VIGEN

B21A Patent or certificate of addition expired [chapter 21.1 patent gazette]

Free format text: PATENTE EXTINTA EM 10/08/2015